Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (2014-2025) 1.4.2 Medications Therapeutics 1.4.3 Medical Devices Therapeutics 1.5 Market by Application 1.5.1 Global Parkinson's Disease Therapeutics Market Share by Application (2014-2025) 1.5.2 Under 40 Years Old 1.5.3 40-65 Years Old 1.5.4 Above 65 Years Old 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Parkinson's Disease Therapeutics Market Size 2.2 Parkinson's Disease Therapeutics Growth Trends by Regions 2.2.1 Parkinson's Disease Therapeutics Market Size by Regions (2014-2025) 2.2.2 Parkinson's Disease Therapeutics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Parkinson's Disease Therapeutics Market Size by Manufacturers 3.1.1 Global Parkinson's Disease Therapeutics Revenue by Manufacturers (2014-2019) 3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Parkinson's Disease Therapeutics Key Players Head office and Area Served 3.3 Key Players Parkinson's Disease Therapeutics Product/Solution/Service 3.4 Date of Enter into Parkinson's Disease Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Parkinson's Disease Therapeutics Market Size by Type (2014-2019) 4.2 Global Parkinson's Disease Therapeutics Market Size by Application (2014-2019) 5 United States 5.1 United States Parkinson's Disease Therapeutics Market Size (2014-2019) 5.2 Parkinson's Disease Therapeutics Key Players in United States 5.3 United States Parkinson's Disease Therapeutics Market Size by Type 5.4 United States Parkinson's Disease Therapeutics Market Size by Application 6 Europe 6.1 Europe Parkinson's Disease Therapeutics Market Size (2014-2019) 6.2 Parkinson's Disease Therapeutics Key Players in Europe 6.3 Europe Parkinson's Disease Therapeutics Market Size by Type 6.4 Europe Parkinson's Disease Therapeutics Market Size by Application 7 China 7.1 China Parkinson's Disease Therapeutics Market Size (2014-2019) 7.2 Parkinson's Disease Therapeutics Key Players in China 7.3 China Parkinson's Disease Therapeutics Market Size by Type 7.4 China Parkinson's Disease Therapeutics Market Size by Application 8 Japan 8.1 Japan Parkinson's Disease Therapeutics Market Size (2014-2019) 8.2 Parkinson's Disease Therapeutics Key Players in Japan 8.3 Japan Parkinson's Disease Therapeutics Market Size by Type 8.4 Japan Parkinson's Disease Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Parkinson's Disease Therapeutics Market Size (2014-2019) 9.2 Parkinson's Disease Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Parkinson's Disease Therapeutics Market Size by Type 9.4 Southeast Asia Parkinson's Disease Therapeutics Market Size by Application 10 India 10.1 India Parkinson's Disease Therapeutics Market Size (2014-2019) 10.2 Parkinson's Disease Therapeutics Key Players in India 10.3 India Parkinson's Disease Therapeutics Market Size by Type 10.4 India Parkinson's Disease Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Parkinson's Disease Therapeutics Market Size (2014-2019) 11.2 Parkinson's Disease Therapeutics Key Players in Central & South America 11.3 Central & South America Parkinson's Disease Therapeutics Market Size by Type 11.4 Central & South America Parkinson's Disease Therapeutics Market Size by Application 12 International Players Profiles 12.1 GSK 12.1.1 GSK Company Details 12.1.2 Company Description and Business Overview 12.1.3 Parkinson's Disease Therapeutics Introduction 12.1.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2014-2019) 12.1.5 GSK Recent Development 12.2 Novartis 12.2.1 Novartis Company Details 12.2.2 Company Description and Business Overview 12.2.3 Parkinson's Disease Therapeutics Introduction 12.2.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2014-2019) 12.2.5 Novartis Recent Development 12.3 Boehringer Ingelheim 12.3.1 Boehringer Ingelheim Company Details 12.3.2 Company Description and Business Overview 12.3.3 Parkinson's Disease Therapeutics Introduction 12.3.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2014-2019) 12.3.5 Boehringer Ingelheim Recent Development 12.4 Teva Pharmaceutical 12.4.1 Teva Pharmaceutical Company Details 12.4.2 Company Description and Business Overview 12.4.3 Parkinson's Disease Therapeutics Introduction 12.4.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2014-2019) 12.4.5 Teva Pharmaceutical Recent Development 12.5 Abbvie 12.5.1 Abbvie Company Details 12.5.2 Company Description and Business Overview 12.5.3 Parkinson's Disease Therapeutics Introduction 12.5.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2014-2019) 12.5.5 Abbvie Recent Development 12.6 Merck 12.6.1 Merck Company Details 12.6.2 Company Description and Business Overview 12.6.3 Parkinson's Disease Therapeutics Introduction 12.6.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2014-2019) 12.6.5 Merck Recent Development 12.7 Akorn 12.7.1 Akorn Company Details 12.7.2 Company Description and Business Overview 12.7.3 Parkinson's Disease Therapeutics Introduction 12.7.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2014-2019) 12.7.5 Akorn Recent Development 12.8 Kyowa Hakko Kirin Pharma 12.8.1 Kyowa Hakko Kirin Pharma Company Details 12.8.2 Company Description and Business Overview 12.8.3 Parkinson's Disease Therapeutics Introduction 12.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2014-2019) 12.8.5 Kyowa Hakko Kirin Pharma Recent Development 12.9 Astellas Pharma 12.9.1 Astellas Pharma Company Details 12.9.2 Company Description and Business Overview 12.9.3 Parkinson's Disease Therapeutics Introduction 12.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2014-2019) 12.9.5 Astellas Pharma Recent Development 12.10 Desitin Arzneimittel 12.10.1 Desitin Arzneimittel Company Details 12.10.2 Company Description and Business Overview 12.10.3 Parkinson's Disease Therapeutics Introduction 12.10.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2014-2019) 12.10.5 Desitin Arzneimittel Recent Development 12.11 Endo Pharmaceuticals 12.12 F.Hoffmann-La Roche 12.13 H.Lundbeck 12.14 Valeant 12.15 Apokyn 12.16 Orion 12.17 Stada Arzneimittel 12.18 US WorldMeds 12.19 Valeant Pharmaceuticals 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Parkinson's Disease Therapeutics Key Market Segments Table Key Players Parkinson's Disease Therapeutics Covered Table Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Parkinson's Disease Therapeutics Market Size Market Share by Type 2014-2025 Figure Medications Therapeutics Figures Table Key Players of Medications Therapeutics Figure Medical Devices Therapeutics Figures Table Key Players of Medical Devices Therapeutics Table Global Parkinson's Disease Therapeutics Market Size Growth by Application 2014-2025 (Million US$) Figure Under 40 Years Old Case Studies Figure 40-65 Years Old Case Studies Figure Above 65 Years Old Case Studies Figure Parkinson's Disease Therapeutics Report Years Considered Table Global Parkinson's Disease Therapeutics Market Size 2014-2025 (Million US$) Figure Global Parkinson's Disease Therapeutics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Parkinson's Disease Therapeutics Market Size by Regions 2014-2025 (Million US$) Table Global Parkinson's Disease Therapeutics Market Size by Regions 2014-2019 (Million US$) Table Global Parkinson's Disease Therapeutics Market Share by Regions 2014-2019 Figure Global Parkinson's Disease Therapeutics Market Share by Regions 2014-2019 Figure Global Parkinson's Disease Therapeutics Market Share by Regions 2019 Table Market Top Trends Table Global Parkinson's Disease Therapeutics Revenue by Manufacturers (2014-2019) (Million US$) Table Global Parkinson's Disease Therapeutics Market Share by Manufacturers (2014-2019) Figure Global Parkinson's Disease Therapeutics Market Share by Manufacturers in 2018 Table Global Parkinson's Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Parkinson's Disease Therapeutics Product/Solution/Service Table Date of Enter into Parkinson's Disease Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$) Table Global Parkinson's Disease Therapeutics Market Size Share by Type (2014-2019) Figure Global Parkinson's Disease Therapeutics Market Size Market Share by Type (2014-2019) Table Global Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$) Table Global Parkinson's Disease Therapeutics Market Size Share by Application (2014-2019) Figure Global Parkinson's Disease Therapeutics Market Size Market Share by Application (2014-2019) Figure Global Parkinson's Disease Therapeutics Revenue Market Share by Application in 2018 Figure United States Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$) Table United States Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$) Table United States Key Players Parkinson's Disease Therapeutics Market Share (2018-2019) Table United States Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$) Table United States Parkinson's Disease Therapeutics Market Share by Type (2014-2019) Table United States Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$) Table United States Parkinson's Disease Therapeutics Market Share by Application (2014-2019) Figure Europe Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$) Table Europe Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$) Table Europe Key Players Parkinson's Disease Therapeutics Market Share (2018-2019) Table Europe Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$) Table Europe Parkinson's Disease Therapeutics Market Share by Type (2014-2019) Table Europe Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$) Table Europe Parkinson's Disease Therapeutics Market Share by Application (2014-2019) Figure China Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$) Table China Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$) Table China Key Players Parkinson's Disease Therapeutics Market Share (2018-2019) Table China Parkinson's Disease Therapeutics Market Size by Type (2014-20189) (Million US$) Table China Parkinson's Disease Therapeutics Market Share by Type (2014-2019) Table China Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$) Table China Parkinson's Disease Therapeutics Market Share by Application (2014-2019) Figure Japan Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$) Table Japan Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$) Table Japan Key Players Parkinson's Disease Therapeutics Market Share (2018-2019) Table Japan Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$) Table Japan Parkinson's Disease Therapeutics Market Share by Type (2014-2019) Table Japan Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$) Table Japan Parkinson's Disease Therapeutics Market Share by Application (2014-2019) Figure Southeast Asia Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Parkinson's Disease Therapeutics Market Share (2018-2019) Table Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Parkinson's Disease Therapeutics Market Share by Type (2014-2019) Table Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Parkinson's Disease Therapeutics Market Share by Application (2014-2019) Figure India Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$) Table India Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$) Table India Key Players Parkinson's Disease Therapeutics Market Share (2018-2019) Table India Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$) Table India Parkinson's Disease Therapeutics Market Share by Type (2014-2019) Table India Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$) Table India Parkinson's Disease Therapeutics Market Share by Application (2014-2019) Figure Central & South America Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Parkinson's Disease Therapeutics Market Share (2018-2019) Table Central & South America Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$) Table Central & South America Parkinson's Disease Therapeutics Market Share by Type (2014-2019) Table Central & South America Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$) Table Central & South America Parkinson's Disease Therapeutics Market Share by Application (2014-2019) Table GSK Company Details Table GSK Revenue in Parkinson's Disease Therapeutics Business (2014-2019) (Million US$) Figure GSK Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019) Table GSK Recent Development Table Novartis Company Details Table Novartis Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019) Table Novartis Recent Development Table Boehringer Ingelheim Company Details Table Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$) Figure Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019) Table Boehringer Ingelheim Recent Development Table Teva Pharmaceutical Company Details Table Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$) Figure Teva Pharmaceutical Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019) Table Teva Pharmaceutical Recent Development Table Abbvie Company Details Table Abbvie Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$) Figure Abbvie Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019) Table Abbvie Recent Development Table Merck Company Details Table Merck Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$) Figure Merck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019) Table Merck Recent Development Table Akorn Company Details Table Akorn Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$) Figure Akorn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019) Table Akorn Recent Development Table Kyowa Hakko Kirin Pharma Company Details Table Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$) Figure Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019) Table Kyowa Hakko Kirin Pharma Recent Development Table Astellas Pharma Company Details Table Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$) Figure Astellas Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019) Table Astellas Pharma Recent Development Table Desitin Arzneimittel Company Details Table Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$) Figure Desitin Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019) Table Desitin Arzneimittel Recent Development Table Endo Pharmaceuticals Company Details Table F.Hoffmann-La Roche Company Details Table H.Lundbeck Company Details Table Valeant Company Details Table Apokyn Company Details Table Orion Company Details Table Stada Arzneimittel Company Details Table US WorldMeds Company Details Table Valeant Pharmaceuticals Company Details Table Global Parkinson's Disease Therapeutics Market Size by Regions (Million US$) 2019-2025 Figure Global Parkinson's Disease Therapeutics Market Size Share by Regions (2019-2025) Figure Global Parkinson's Disease Therapeutics Market Size Share by Regions in 2025 Figure United States Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Europe Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure China Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Japan Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure India Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD) Table Global Parkinson's Disease Therapeutics Market Size by Product (2019-2025) (Million US$) Figure Global Parkinson's Disease Therapeutics Market Size by Product (2019-2025) Figure Global Parkinson's Disease Therapeutics Market Size by Product in 2025 Table Global Parkinson's Disease Therapeutics Market Size by Application (2019-2025) (Million US$) Figure Global Parkinson's Disease Therapeutics Market Size by Application (2019-2025) Figure Global Parkinson's Disease Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie Merck Akorn Kyowa Hakko Kirin Pharma Astellas Pharma Desitin Arzneimittel Endo Pharmaceuticals F.Hoffmann-La Roche H.Lundbeck Valeant Apokyn Orion Stada Arzneimittel US WorldMeds Valeant Pharmaceuticals